title: Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy.
authors.forename: Tzu-Chieh
authors.initials: TC
authors.lastname: Yin
authors.forename: Wen-Chieh
authors.initials: WC
authors.lastname: Fan
authors.forename: Che-Jen
authors.initials: CJ
authors.lastname: Huang
authors.forename: Jan-Sing
authors.initials: JS
authors.lastname: Hsieh
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides / Q000009:adverse effects*; D018450:Disease Progression; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D006465:Hemoperitoneum / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D007583:Jejunum / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate